Hennion & Walsh Asset Management, Inc. Kiniksa Pharmaceuticals, Ltd. Call Options Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.59 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KNSA
# of Institutions
7Shares Held
1.85MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$56.8 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$7.59 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$1.48 Million0.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$1.12 Million0.87% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$1.08 Million0.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $1.29B
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...